Fermion-Header

Fermion-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Lonza Group

Global Pharmaceutical Dosage Solutions Company

Contact Supplier

Contact Supplier

Digital Content

SupplySide West 2021

Participation Not Confirmed

Update your Virtual Booth

Kodiak, Lonza Sign Long-Term Manufacturing Contract

Lead Product(s): KSI-301

Therapeutic Area: Ophthalmology Product Name: KSI-301

Highest Development Status: Phase II/ Phase III Product Type: Large molecule

Partner/Sponsor/Collaborator: Kodiak Sciences

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement July 27, 2020

Details:

Purpose-built bioconjugation facility in Lonza’s Ibex™ Dedicate Biopark to support the potential commercial launch of Kodiak's leading ophthalm